Baseimmune
Baseimmune is a pioneering biotech company founded in 2019, focused on revolutionizing vaccine development through advanced computational antigen design. Their mission is to harness data science, machine learning, and computational biology to create cross-protective, mutation-proof vaccines, aiming to develop vaccines that can protect against current and future variants of infectious diseases.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Pipeline of antigen candidates for human and veterinary vaccines
A set of antigen candidates under preclinical development targeting diseases such as malaria, SARS-CoV-2 (COVID) and African swine fever virus, intended for progression toward clinical evaluation or collaborator development.
Pipeline of antigen candidates for human and veterinary vaccines
A set of antigen candidates under preclinical development targeting diseases such as malaria, SARS-CoV-2 (COVID) and African swine fever virus, intended for progression toward clinical evaluation or collaborator development.
Services
Generation of vaccine antigen candidates for human and veterinary diseases using machine learning and evolutionary analysis to prioritise antigens covering multiple strains and potential future variants.
Design, optimisation and execution of cell-based immunoassays and preclinical immunology studies to quantify and characterise T cell responses and support vaccine evaluation.
Design and operation of compute infrastructure, automation, CI/CD pipelines and big-data workflows to support computational biology and antigen design projects.
Generation of vaccine antigen candidates for human and veterinary diseases using machine learning and evolutionary analysis to prioritise antigens covering multiple strains and potential future variants.
Design, optimisation and execution of cell-based immunoassays and preclinical immunology studies to quantify and characterise T cell responses and support vaccine evaluation.
Design and operation of compute infrastructure, automation, CI/CD pipelines and big-data workflows to support computational biology and antigen design projects.
Expertise Areas
- Computational vaccine design
- Antigen design and discovery
- Translational immunology
- T cell immunology and functional assays
Key Technologies
- Machine learning for antigen design
- High-performance computing (HPC)
- Big data analytics
- Evolutionary modelling
News & Updates
Baseimmune raised a £685,000 investment led by Creator Fund, with support from Vaccitech, Oxford University, and Imperial College London. They are working on future COVID and Malaria vaccines, and have designed over 15 vaccines, including a multi-genotype therapeutic vaccine against HPV.
Baseimmune's team has designed over 15 vaccines, with two in human clinical trials, including the world's first multi-genotype therapeutic HPV vaccine.
Baseimmune raised a £685,000 investment led by Creator Fund, with support from Vaccitech, Oxford University, and Imperial College London. They are working on future COVID and Malaria vaccines, and have designed over 15 vaccines, including a multi-genotype therapeutic vaccine against HPV.
Baseimmune's team has designed over 15 vaccines, with two in human clinical trials, including the world's first multi-genotype therapeutic HPV vaccine.